TABLE 2

Evaluation of clinical isolates for 33X1 and 33X2

StrainSerotypeSourcePool Eafs20bbHyp33FG1cHPCG2bd
BLS10133AThis study++±
BLS10333FThis study++
BLS10433X1This study+++
BLS14033X2This study+++
TIGRJSNonencapsulatedUAB+
SSISP33A33AeSSI++
3085-0633ACDC++±
5467-0633ACDC++±
SSISP33F33FSSI++
BG669233FUAB++
0126-0633FCDC++
1258-0633FCDC++
2289-0633FCDC++
3052-0633FCDC++
3061-0633FCDC++
3075-0633FCDC++
3112-0633FCDC++
3124-0633FCDC++
3999-0633FCDC++
4064-0633FCDC++
4904-0633FCDC++
4157-0633FCDC+±
4781-0633FCDC++±
5065-0633FCDC++
MNZ101033FCDC+±
SJY07-13533FKorea University Guro Hospital++
  • a Geometric mean fluorescence of Pool E: +, >200; −, <6.

  • b Geometric mean fluorescence of fs20b: +, >1,000; −, <250.

  • c Geometric mean fluorescence of Hyp33FG1: +, >80; ±, 6 to 80; −, <6.

  • d Geometric mean fluorescence of HPCG2b: +, >40; ±, 6 to 40; −, <6.

  • e Strain SSISP33A was annotated here as serotype 33A because it was provided to us by SSI as serotype 33A. However, SSISP33A has a defective wcjE (genetic basis for serotype 33F [see Table S2 in the supplemental material]) and is serologically serotype 33F.